遊離脂肪酸受容体4の世界市場（～2026年）

• 英文タイトル：Global Free Fatty Acid Receptor 4 Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY06507 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料は遊離脂肪酸受容体4のグローバル市場について調査・分析したレポートです。種類別（CB-001、GSK-137647A、SC-410、その他）市場規模、用途別（非アルコール性脂肪性肝疾患、2型糖尿病、代謝性疾患、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別遊離脂肪酸受容体4の競争状況、市場シェア ・世界の遊離脂肪酸受容体4市場：種類別市場規模 2015年-2020年（CB-001、GSK-137647A、SC-410、その他） ・世界の遊離脂肪酸受容体4市場：種類別市場規模予測 2021年-2026年（CB-001、GSK-137647A、SC-410、その他） ・世界の遊離脂肪酸受容体4市場：用途別市場規模 2015年-2020年（非アルコール性脂肪性肝疾患、2型糖尿病、代謝性疾患、その他） ・世界の遊離脂肪酸受容体4市場：用途別市場規模予測 2021年-2026年（非アルコール性脂肪性肝疾患、2型糖尿病、代謝性疾患、その他） ・北米の遊離脂肪酸受容体4市場分析：米国、カナダ ・ヨーロッパの遊離脂肪酸受容体4市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの遊離脂肪酸受容体4市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の遊離脂肪酸受容体4市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの遊離脂肪酸受容体4市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Advinus Therapeutics Ltd、AstraZeneca Plc、CymaBay Therapeutics Inc、Dompe Farmaceutici SpA、GlaxoSmithKline Plc、Merck & Co Inc、Sancilio & Company Inc ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Market Analysis and Insights: Global Free Fatty Acid Receptor 4 Market
The global Free Fatty Acid Receptor 4 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Free Fatty Acid Receptor 4 Scope and Market Size
Free Fatty Acid Receptor 4 market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Free Fatty Acid Receptor 4 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Free Fatty Acid Receptor 4 market is segmented into
CB-001
GSK-137647A
SC-410
Others

Segment by Application, the Free Fatty Acid Receptor 4 market is segmented into
Non Alcoholic Fatty Liver Disease
Type 2 Diabets
Metabolic Disorders
Others

Regional and Country-level Analysis
The Free Fatty Acid Receptor 4 market is analysed and market size information is provided by regions (countries).
The key regions covered in the Free Fatty Acid Receptor 4 market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Free Fatty Acid Receptor 4 Market Share Analysis
Free Fatty Acid Receptor 4 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Free Fatty Acid Receptor 4 business, the date to enter into the Free Fatty Acid Receptor 4 market, Free Fatty Acid Receptor 4 product introduction, recent developments, etc.

The major vendors covered:
Advinus Therapeutics Ltd
AstraZeneca Plc
CymaBay Therapeutics Inc
Dompe Farmaceutici SpA
GlaxoSmithKline Plc
Merck & Co Inc
Sancilio & Company Inc
…

レポート目次

---

1 Study Coverage
1.1 Free Fatty Acid Receptor 4 Product Introduction
1.2 Market Segments
1.3 Key Free Fatty Acid Receptor 4 Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Free Fatty Acid Receptor 4 Market Size Growth Rate by Type
1.4.2 CB-001
1.4.3 GSK-137647A
1.4.4 SC-410
1.4.5 Others
1.5 Market by Application
1.5.1 Global Free Fatty Acid Receptor 4 Market Size Growth Rate by Application
1.5.2 Non Alcoholic Fatty Liver Disease
1.5.3 Type 2 Diabets
1.5.4 Metabolic Disorders
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Free Fatty Acid Receptor 4 Market Size, Estimates and Forecasts
2.1.1 Global Free Fatty Acid Receptor 4 Revenue 2015-2026
2.1.2 Global Free Fatty Acid Receptor 4 Sales 2015-2026
2.2 Global Free Fatty Acid Receptor 4, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Free Fatty Acid Receptor 4 Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Free Fatty Acid Receptor 4 Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Free Fatty Acid Receptor 4 Competitor Landscape by Players
3.1 Free Fatty Acid Receptor 4 Sales by Manufacturers
3.1.1 Free Fatty Acid Receptor 4 Sales by Manufacturers (2015-2020)
3.1.2 Free Fatty Acid Receptor 4 Sales Market Share by Manufacturers (2015-2020)
3.2 Free Fatty Acid Receptor 4 Revenue by Manufacturers
3.2.1 Free Fatty Acid Receptor 4 Revenue by Manufacturers (2015-2020)
3.2.2 Free Fatty Acid Receptor 4 Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Free Fatty Acid Receptor 4 Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Free Fatty Acid Receptor 4 Revenue in 2019
3.2.5 Global Free Fatty Acid Receptor 4 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Free Fatty Acid Receptor 4 Price by Manufacturers
3.4 Free Fatty Acid Receptor 4 Manufacturing Base Distribution, Product Types
3.4.1 Free Fatty Acid Receptor 4 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Free Fatty Acid Receptor 4 Product Type
3.4.3 Date of International Manufacturers Enter into Free Fatty Acid Receptor 4 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Free Fatty Acid Receptor 4 Market Size by Type (2015-2020)
4.1.1 Global Free Fatty Acid Receptor 4 Sales by Type (2015-2020)
4.1.2 Global Free Fatty Acid Receptor 4 Revenue by Type (2015-2020)
4.1.3 Free Fatty Acid Receptor 4 Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Free Fatty Acid Receptor 4 Market Size Forecast by Type (2021-2026)
4.2.1 Global Free Fatty Acid Receptor 4 Sales Forecast by Type (2021-2026)
4.2.2 Global Free Fatty Acid Receptor 4 Revenue Forecast by Type (2021-2026)
4.2.3 Free Fatty Acid Receptor 4 Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Free Fatty Acid Receptor 4 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Free Fatty Acid Receptor 4 Market Size by Application (2015-2020)
5.1.1 Global Free Fatty Acid Receptor 4 Sales by Application (2015-2020)
5.1.2 Global Free Fatty Acid Receptor 4 Revenue by Application (2015-2020)
5.1.3 Free Fatty Acid Receptor 4 Price by Application (2015-2020)
5.2 Free Fatty Acid Receptor 4 Market Size Forecast by Application (2021-2026)
5.2.1 Global Free Fatty Acid Receptor 4 Sales Forecast by Application (2021-2026)
5.2.2 Global Free Fatty Acid Receptor 4 Revenue Forecast by Application (2021-2026)
5.2.3 Global Free Fatty Acid Receptor 4 Price Forecast by Application (2021-2026)

6 North America
6.1 North America Free Fatty Acid Receptor 4 by Country
6.1.1 North America Free Fatty Acid Receptor 4 Sales by Country
6.1.2 North America Free Fatty Acid Receptor 4 Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Free Fatty Acid Receptor 4 Market Facts & Figures by Type
6.3 North America Free Fatty Acid Receptor 4 Market Facts & Figures by Application

7 Europe
7.1 Europe Free Fatty Acid Receptor 4 by Country
7.1.1 Europe Free Fatty Acid Receptor 4 Sales by Country
7.1.2 Europe Free Fatty Acid Receptor 4 Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Free Fatty Acid Receptor 4 Market Facts & Figures by Type
7.3 Europe Free Fatty Acid Receptor 4 Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Free Fatty Acid Receptor 4 by Region
8.1.1 Asia Pacific Free Fatty Acid Receptor 4 Sales by Region
8.1.2 Asia Pacific Free Fatty Acid Receptor 4 Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Free Fatty Acid Receptor 4 Market Facts & Figures by Type
8.3 Asia Pacific Free Fatty Acid Receptor 4 Market Facts & Figures by Application

9 Latin America
9.1 Latin America Free Fatty Acid Receptor 4 by Country
9.1.1 Latin America Free Fatty Acid Receptor 4 Sales by Country
9.1.2 Latin America Free Fatty Acid Receptor 4 Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Free Fatty Acid Receptor 4 Market Facts & Figures by Type
9.3 Central & South America Free Fatty Acid Receptor 4 Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Free Fatty Acid Receptor 4 by Country
10.1.1 Middle East and Africa Free Fatty Acid Receptor 4 Sales by Country
10.1.2 Middle East and Africa Free Fatty Acid Receptor 4 Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Free Fatty Acid Receptor 4 Market Facts & Figures by Type
10.3 Middle East and Africa Free Fatty Acid Receptor 4 Market Facts & Figures by Application

11 Company Profiles
11.1 Advinus Therapeutics Ltd
11.1.1 Advinus Therapeutics Ltd Corporation Information
11.1.2 Advinus Therapeutics Ltd Description and Business Overview
11.1.3 Advinus Therapeutics Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Advinus Therapeutics Ltd Free Fatty Acid Receptor 4 Products Offered
11.1.5 Advinus Therapeutics Ltd Related Developments
11.2 AstraZeneca Plc
11.2.1 AstraZeneca Plc Corporation Information
11.2.2 AstraZeneca Plc Description and Business Overview
11.2.3 AstraZeneca Plc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 AstraZeneca Plc Free Fatty Acid Receptor 4 Products Offered
11.2.5 AstraZeneca Plc Related Developments
11.3 CymaBay Therapeutics Inc
11.3.1 CymaBay Therapeutics Inc Corporation Information
11.3.2 CymaBay Therapeutics Inc Description and Business Overview
11.3.3 CymaBay Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 CymaBay Therapeutics Inc Free Fatty Acid Receptor 4 Products Offered
11.3.5 CymaBay Therapeutics Inc Related Developments
11.4 Dompe Farmaceutici SpA
11.4.1 Dompe Farmaceutici SpA Corporation Information
11.4.2 Dompe Farmaceutici SpA Description and Business Overview
11.4.3 Dompe Farmaceutici SpA Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Dompe Farmaceutici SpA Free Fatty Acid Receptor 4 Products Offered
11.4.5 Dompe Farmaceutici SpA Related Developments
11.5 GlaxoSmithKline Plc
11.5.1 GlaxoSmithKline Plc Corporation Information
11.5.2 GlaxoSmithKline Plc Description and Business Overview
11.5.3 GlaxoSmithKline Plc Sales, Revenue and Gross Margin (2015-2020)
11.5.4 GlaxoSmithKline Plc Free Fatty Acid Receptor 4 Products Offered
11.5.5 GlaxoSmithKline Plc Related Developments
11.6 Merck & Co Inc
11.6.1 Merck & Co Inc Corporation Information
11.6.2 Merck & Co Inc Description and Business Overview
11.6.3 Merck & Co Inc Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Merck & Co Inc Free Fatty Acid Receptor 4 Products Offered
11.6.5 Merck & Co Inc Related Developments
11.7 Sancilio & Company Inc
11.7.1 Sancilio & Company Inc Corporation Information
11.7.2 Sancilio & Company Inc Description and Business Overview
11.7.3 Sancilio & Company Inc Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Sancilio & Company Inc Free Fatty Acid Receptor 4 Products Offered
11.7.5 Sancilio & Company Inc Related Developments
11.1 Advinus Therapeutics Ltd
11.1.1 Advinus Therapeutics Ltd Corporation Information
11.1.2 Advinus Therapeutics Ltd Description and Business Overview
11.1.3 Advinus Therapeutics Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Advinus Therapeutics Ltd Free Fatty Acid Receptor 4 Products Offered
11.1.5 Advinus Therapeutics Ltd Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Free Fatty Acid Receptor 4 Market Estimates and Projections by Region
12.1.1 Global Free Fatty Acid Receptor 4 Sales Forecast by Regions 2021-2026
12.1.2 Global Free Fatty Acid Receptor 4 Revenue Forecast by Regions 2021-2026
12.2 North America Free Fatty Acid Receptor 4 Market Size Forecast (2021-2026)
12.2.1 North America: Free Fatty Acid Receptor 4 Sales Forecast (2021-2026)
12.2.2 North America: Free Fatty Acid Receptor 4 Revenue Forecast (2021-2026)
12.2.3 North America: Free Fatty Acid Receptor 4 Market Size Forecast by Country (2021-2026)
12.3 Europe Free Fatty Acid Receptor 4 Market Size Forecast (2021-2026)
12.3.1 Europe: Free Fatty Acid Receptor 4 Sales Forecast (2021-2026)
12.3.2 Europe: Free Fatty Acid Receptor 4 Revenue Forecast (2021-2026)
12.3.3 Europe: Free Fatty Acid Receptor 4 Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Free Fatty Acid Receptor 4 Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Free Fatty Acid Receptor 4 Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Free Fatty Acid Receptor 4 Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Free Fatty Acid Receptor 4 Market Size Forecast by Region (2021-2026)
12.5 Latin America Free Fatty Acid Receptor 4 Market Size Forecast (2021-2026)
12.5.1 Latin America: Free Fatty Acid Receptor 4 Sales Forecast (2021-2026)
12.5.2 Latin America: Free Fatty Acid Receptor 4 Revenue Forecast (2021-2026)
12.5.3 Latin America: Free Fatty Acid Receptor 4 Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Free Fatty Acid Receptor 4 Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Free Fatty Acid Receptor 4 Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Free Fatty Acid Receptor 4 Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Free Fatty Acid Receptor 4 Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Free Fatty Acid Receptor 4 Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Free Fatty Acid Receptor 4 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Free Fatty Acid Receptor 4 Market Segments
Table 2. Ranking of Global Top Free Fatty Acid Receptor 4 Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Free Fatty Acid Receptor 4 Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of CB-001
Table 5. Major Manufacturers of GSK-137647A
Table 6. Major Manufacturers of SC-410
Table 7. Major Manufacturers of Others
Table 8. Global Free Fatty Acid Receptor 4 Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 9. Global Free Fatty Acid Receptor 4 Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 10. Global Free Fatty Acid Receptor 4 Sales by Regions 2015-2020 (K Pcs)
Table 11. Global Free Fatty Acid Receptor 4 Sales Market Share by Regions (2015-2020)
Table 12. Global Free Fatty Acid Receptor 4 Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Free Fatty Acid Receptor 4 Sales by Manufacturers (2015-2020) (K Pcs)
Table 14. Global Free Fatty Acid Receptor 4 Sales Share by Manufacturers (2015-2020)
Table 15. Global Free Fatty Acid Receptor 4 Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Free Fatty Acid Receptor 4 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Free Fatty Acid Receptor 4 as of 2019)
Table 17. Free Fatty Acid Receptor 4 Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Free Fatty Acid Receptor 4 Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Free Fatty Acid Receptor 4 Price (2015-2020) (USD/Pcs)
Table 20. Free Fatty Acid Receptor 4 Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Free Fatty Acid Receptor 4 Product Type
Table 22. Date of International Manufacturers Enter into Free Fatty Acid Receptor 4 Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Free Fatty Acid Receptor 4 Sales by Type (2015-2020) (K Pcs)
Table 25. Global Free Fatty Acid Receptor 4 Sales Share by Type (2015-2020)
Table 26. Global Free Fatty Acid Receptor 4 Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Free Fatty Acid Receptor 4 Revenue Share by Type (2015-2020)
Table 28. Free Fatty Acid Receptor 4 Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 29. Global Free Fatty Acid Receptor 4 Sales by Application (2015-2020) (K Pcs)
Table 30. Global Free Fatty Acid Receptor 4 Sales Share by Application (2015-2020)
Table 31. North America Free Fatty Acid Receptor 4 Sales by Country (2015-2020) (K Pcs)
Table 32. North America Free Fatty Acid Receptor 4 Sales Market Share by Country (2015-2020)
Table 33. North America Free Fatty Acid Receptor 4 Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Free Fatty Acid Receptor 4 Revenue Market Share by Country (2015-2020)
Table 35. North America Free Fatty Acid Receptor 4 Sales by Type (2015-2020) (K Pcs)
Table 36. North America Free Fatty Acid Receptor 4 Sales Market Share by Type (2015-2020)
Table 37. North America Free Fatty Acid Receptor 4 Sales by Application (2015-2020) (K Pcs)
Table 38. North America Free Fatty Acid Receptor 4 Sales Market Share by Application (2015-2020)
Table 39. Europe Free Fatty Acid Receptor 4 Sales by Country (2015-2020) (K Pcs)
Table 40. Europe Free Fatty Acid Receptor 4 Sales Market Share by Country (2015-2020)
Table 41. Europe Free Fatty Acid Receptor 4 Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Free Fatty Acid Receptor 4 Revenue Market Share by Country (2015-2020)
Table 43. Europe Free Fatty Acid Receptor 4 Sales by Type (2015-2020) (K Pcs)
Table 44. Europe Free Fatty Acid Receptor 4 Sales Market Share by Type (2015-2020)
Table 45. Europe Free Fatty Acid Receptor 4 Sales by Application (2015-2020) (K Pcs)
Table 46. Europe Free Fatty Acid Receptor 4 Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Free Fatty Acid Receptor 4 Sales by Region (2015-2020) (K Pcs)
Table 48. Asia Pacific Free Fatty Acid Receptor 4 Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Free Fatty Acid Receptor 4 Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Free Fatty Acid Receptor 4 Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Free Fatty Acid Receptor 4 Sales by Type (2015-2020) (K Pcs)
Table 52. Asia Pacific Free Fatty Acid Receptor 4 Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Free Fatty Acid Receptor 4 Sales by Application (2015-2020) (K Pcs)
Table 54. Asia Pacific Free Fatty Acid Receptor 4 Sales Market Share by Application (2015-2020)
Table 55. Latin America Free Fatty Acid Receptor 4 Sales by Country (2015-2020) (K Pcs)
Table 56. Latin America Free Fatty Acid Receptor 4 Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Free Fatty Acid Receptor 4 Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Free Fatty Acid Receptor 4 Revenue Market Share by Country (2015-2020)
Table 59. Latin America Free Fatty Acid Receptor 4 Sales by Type (2015-2020) (K Pcs)
Table 60. Latin America Free Fatty Acid Receptor 4 Sales Market Share by Type (2015-2020)
Table 61. Latin America Free Fatty Acid Receptor 4 Sales by Application (2015-2020) (K Pcs)
Table 62. Latin America Free Fatty Acid Receptor 4 Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Free Fatty Acid Receptor 4 Sales by Country (2015-2020) (K Pcs)
Table 64. Middle East and Africa Free Fatty Acid Receptor 4 Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Free Fatty Acid Receptor 4 Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Free Fatty Acid Receptor 4 Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Free Fatty Acid Receptor 4 Sales by Type (2015-2020) (K Pcs)
Table 68. Middle East and Africa Free Fatty Acid Receptor 4 Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Free Fatty Acid Receptor 4 Sales by Application (2015-2020) (K Pcs)
Table 70. Middle East and Africa Free Fatty Acid Receptor 4 Sales Market Share by Application (2015-2020)
Table 71. Advinus Therapeutics Ltd Corporation Information
Table 72. Advinus Therapeutics Ltd Description and Major Businesses
Table 73. Advinus Therapeutics Ltd Free Fatty Acid Receptor 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 74. Advinus Therapeutics Ltd Product
Table 75. Advinus Therapeutics Ltd Recent Development
Table 76. AstraZeneca Plc Corporation Information
Table 77. AstraZeneca Plc Description and Major Businesses
Table 78. AstraZeneca Plc Free Fatty Acid Receptor 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 79. AstraZeneca Plc Product
Table 80. AstraZeneca Plc Recent Development
Table 81. CymaBay Therapeutics Inc Corporation Information
Table 82. CymaBay Therapeutics Inc Description and Major Businesses
Table 83. CymaBay Therapeutics Inc Free Fatty Acid Receptor 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 84. CymaBay Therapeutics Inc Product
Table 85. CymaBay Therapeutics Inc Recent Development
Table 86. Dompe Farmaceutici SpA Corporation Information
Table 87. Dompe Farmaceutici SpA Description and Major Businesses
Table 88. Dompe Farmaceutici SpA Free Fatty Acid Receptor 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 89. Dompe Farmaceutici SpA Product
Table 90. Dompe Farmaceutici SpA Recent Development
Table 91. GlaxoSmithKline Plc Corporation Information
Table 92. GlaxoSmithKline Plc Description and Major Businesses
Table 93. GlaxoSmithKline Plc Free Fatty Acid Receptor 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 94. GlaxoSmithKline Plc Product
Table 95. GlaxoSmithKline Plc Recent Development
Table 96. Merck & Co Inc Corporation Information
Table 97. Merck & Co Inc Description and Major Businesses
Table 98. Merck & Co Inc Free Fatty Acid Receptor 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 99. Merck & Co Inc Product
Table 100. Merck & Co Inc Recent Development
Table 101. Sancilio & Company Inc Corporation Information
Table 102. Sancilio & Company Inc Description and Major Businesses
Table 103. Sancilio & Company Inc Free Fatty Acid Receptor 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 104. Sancilio & Company Inc Product
Table 105. Sancilio & Company Inc Recent Development
Table 106. Global Free Fatty Acid Receptor 4 Sales Forecast by Regions (2021-2026) (K Pcs)
Table 107. Global Free Fatty Acid Receptor 4 Sales Market Share Forecast by Regions (2021-2026)
Table 108. Global Free Fatty Acid Receptor 4 Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 109. Global Free Fatty Acid Receptor 4 Revenue Market Share Forecast by Regions (2021-2026)
Table 110. North America: Free Fatty Acid Receptor 4 Sales Forecast by Country (2021-2026) (K Pcs)
Table 111. North America: Free Fatty Acid Receptor 4 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 112. Europe: Free Fatty Acid Receptor 4 Sales Forecast by Country (2021-2026) (K Pcs)
Table 113. Europe: Free Fatty Acid Receptor 4 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 114. Asia Pacific: Free Fatty Acid Receptor 4 Sales Forecast by Region (2021-2026) (K Pcs)
Table 115. Asia Pacific: Free Fatty Acid Receptor 4 Revenue Forecast by Region (2021-2026) (US$ Million)
Table 116. Latin America: Free Fatty Acid Receptor 4 Sales Forecast by Country (2021-2026) (K Pcs)
Table 117. Latin America: Free Fatty Acid Receptor 4 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Middle East and Africa: Free Fatty Acid Receptor 4 Sales Forecast by Country (2021-2026) (K Pcs)
Table 119. Middle East and Africa: Free Fatty Acid Receptor 4 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 120. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 121. Key Challenges
Table 122. Market Risks
Table 123. Main Points Interviewed from Key Free Fatty Acid Receptor 4 Players
Table 124. Free Fatty Acid Receptor 4 Customers List
Table 125. Free Fatty Acid Receptor 4 Distributors List
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Free Fatty Acid Receptor 4 Product Picture
Figure 2. Global Free Fatty Acid Receptor 4 Sales Market Share by Type in 2020 & 2026
Figure 3. CB-001 Product Picture
Figure 4. GSK-137647A Product Picture
Figure 5. SC-410 Product Picture
Figure 6. Others Product Picture
Figure 7. Global Free Fatty Acid Receptor 4 Sales Market Share by Application in 2020 & 2026
Figure 8. Non Alcoholic Fatty Liver Disease
Figure 9. Type 2 Diabets
Figure 10. Metabolic Disorders
Figure 11. Others
Figure 12. Free Fatty Acid Receptor 4 Report Years Considered
Figure 13. Global Free Fatty Acid Receptor 4 Market Size 2015-2026 (US$ Million)
Figure 14. Global Free Fatty Acid Receptor 4 Sales 2015-2026 (K Pcs)
Figure 15. Global Free Fatty Acid Receptor 4 Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Free Fatty Acid Receptor 4 Sales Market Share by Region (2015-2020)
Figure 17. Global Free Fatty Acid Receptor 4 Sales Market Share by Region in 2019
Figure 18. Global Free Fatty Acid Receptor 4 Revenue Market Share by Region (2015-2020)
Figure 19. Global Free Fatty Acid Receptor 4 Revenue Market Share by Region in 2019
Figure 20. Global Free Fatty Acid Receptor 4 Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Free Fatty Acid Receptor 4 Revenue in 2019
Figure 22. Free Fatty Acid Receptor 4 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Free Fatty Acid Receptor 4 Sales Market Share by Type (2015-2020)
Figure 24. Global Free Fatty Acid Receptor 4 Sales Market Share by Type in 2019
Figure 25. Global Free Fatty Acid Receptor 4 Revenue Market Share by Type (2015-2020)
Figure 26. Global Free Fatty Acid Receptor 4 Revenue Market Share by Type in 2019
Figure 27. Global Free Fatty Acid Receptor 4 Market Share by Price Range (2015-2020)
Figure 28. Global Free Fatty Acid Receptor 4 Sales Market Share by Application (2015-2020)
Figure 29. Global Free Fatty Acid Receptor 4 Sales Market Share by Application in 2019
Figure 30. Global Free Fatty Acid Receptor 4 Revenue Market Share by Application (2015-2020)
Figure 31. Global Free Fatty Acid Receptor 4 Revenue Market Share by Application in 2019
Figure 32. North America Free Fatty Acid Receptor 4 Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Free Fatty Acid Receptor 4 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Free Fatty Acid Receptor 4 Sales Market Share by Country in 2019
Figure 35. North America Free Fatty Acid Receptor 4 Revenue Market Share by Country in 2019
Figure 36. U.S. Free Fatty Acid Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Free Fatty Acid Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Free Fatty Acid Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Free Fatty Acid Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Free Fatty Acid Receptor 4 Market Share by Type in 2019
Figure 41. North America Free Fatty Acid Receptor 4 Market Share by Application in 2019
Figure 42. Europe Free Fatty Acid Receptor 4 Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Free Fatty Acid Receptor 4 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Free Fatty Acid Receptor 4 Sales Market Share by Country in 2019
Figure 45. Europe Free Fatty Acid Receptor 4 Revenue Market Share by Country in 2019
Figure 46. Germany Free Fatty Acid Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Free Fatty Acid Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Free Fatty Acid Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Free Fatty Acid Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Free Fatty Acid Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Free Fatty Acid Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Free Fatty Acid Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Free Fatty Acid Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Free Fatty Acid Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Free Fatty Acid Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Free Fatty Acid Receptor 4 Market Share by Type in 2019
Figure 57. Europe Free Fatty Acid Receptor 4 Market Share by Application in 2019
Figure 58. Asia Pacific Free Fatty Acid Receptor 4 Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Free Fatty Acid Receptor 4 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Free Fatty Acid Receptor 4 Sales Market Share by Region in 2019
Figure 61. Asia Pacific Free Fatty Acid Receptor 4 Revenue Market Share by Region in 2019
Figure 62. China Free Fatty Acid Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Free Fatty Acid Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Free Fatty Acid Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Free Fatty Acid Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Free Fatty Acid Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Free Fatty Acid Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Free Fatty Acid Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Free Fatty Acid Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Free Fatty Acid Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Free Fatty Acid Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Free Fatty Acid Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Free Fatty Acid Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Free Fatty Acid Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Free Fatty Acid Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Free Fatty Acid Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Free Fatty Acid Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Free Fatty Acid Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Free Fatty Acid Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Free Fatty Acid Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Free Fatty Acid Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Free Fatty Acid Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Free Fatty Acid Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Free Fatty Acid Receptor 4 Market Share by Type in 2019
Figure 85. Asia Pacific Free Fatty Acid Receptor 4 Market Share by Application in 2019
Figure 86. Latin America Free Fatty Acid Receptor 4 Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Free Fatty Acid Receptor 4 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Free Fatty Acid Receptor 4 Sales Market Share by Country in 2019
Figure 89. Latin America Free Fatty Acid Receptor 4 Revenue Market Share by Country in 2019
Figure 90. Mexico Free Fatty Acid Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Free Fatty Acid Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Free Fatty Acid Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Free Fatty Acid Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Free Fatty Acid Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Free Fatty Acid Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Free Fatty Acid Receptor 4 Market Share by Type in 2019
Figure 97. Latin America Free Fatty Acid Receptor 4 Market Share by Application in 2019
Figure 98. Middle East and Africa Free Fatty Acid Receptor 4 Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Free Fatty Acid Receptor 4 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Free Fatty Acid Receptor 4 Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Free Fatty Acid Receptor 4 Revenue Market Share by Country in 2019
Figure 102. Turkey Free Fatty Acid Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Free Fatty Acid Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Free Fatty Acid Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Free Fatty Acid Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Free Fatty Acid Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Free Fatty Acid Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Free Fatty Acid Receptor 4 Market Share by Type in 2019
Figure 109. Middle East and Africa Free Fatty Acid Receptor 4 Market Share by Application in 2019
Figure 110. North America Free Fatty Acid Receptor 4 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America Free Fatty Acid Receptor 4 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Free Fatty Acid Receptor 4 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe Free Fatty Acid Receptor 4 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Free Fatty Acid Receptor 4 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific Free Fatty Acid Receptor 4 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Free Fatty Acid Receptor 4 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America Free Fatty Acid Receptor 4 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Free Fatty Acid Receptor 4 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa Free Fatty Acid Receptor 4 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed

---